196 related articles for article (PubMed ID: 12829026)
1. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.
Kirchner D; Duyster J; Ottmann O; Schmid RM; Bergmann L; Munzert G
Exp Hematol; 2003 Jun; 31(6):504-11. PubMed ID: 12829026
[TBL] [Abstract][Full Text] [Related]
2. Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Munzert G; Kirchner D; Ottmann O; Bergmann L; Schmid RM
Leuk Lymphoma; 2004 Jun; 45(6):1181-4. PubMed ID: 15359998
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
Lu Y; Jamieson L; Brasier AR; Fields AP
Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
[TBL] [Abstract][Full Text] [Related]
4. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
Reuther JY; Reuther GW; Cortez D; Pendergast AM; Baldwin AS
Genes Dev; 1998 Apr; 12(7):968-81. PubMed ID: 9531535
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors.
Mukhopadhyay A; Shishodia S; Suttles J; Brittingham K; Lamothe B; Nimmanapalli R; Bhalla KN; Aggarwal BB
J Biol Chem; 2002 Aug; 277(34):30622-8. PubMed ID: 12060665
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
[TBL] [Abstract][Full Text] [Related]
7. IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1.
Hsieh MY; Van Etten RA
Blood; 2014 Apr; 123(15):2401-11. PubMed ID: 24464015
[TBL] [Abstract][Full Text] [Related]
8. The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.
Carrà G; Torti D; Crivellaro S; Panuzzo C; Taulli R; Cilloni D; Guerrasio A; Saglio G; Morotti A
Oncotarget; 2016 Oct; 7(40):66287-66298. PubMed ID: 27563822
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
O'Mahony AM; Montano M; Van Beneden K; Chen LF; Greene WC
J Biol Chem; 2004 Apr; 279(18):18137-45. PubMed ID: 14963024
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected.
Ruby CE; Leid M; Kerkvliet NI
Mol Pharmacol; 2002 Sep; 62(3):722-8. PubMed ID: 12181450
[TBL] [Abstract][Full Text] [Related]
12. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.
Rayet B; Fan Y; Gélinas C
Mol Cell Biol; 2003 Mar; 23(5):1520-33. PubMed ID: 12588973
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel.
Martin AG; Fresno M
J Biol Chem; 2000 Aug; 275(32):24383-91. PubMed ID: 10823840
[TBL] [Abstract][Full Text] [Related]
15. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
16. Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).
Hamdane M; David-Cordonnier MH; D'Halluin JC
Oncogene; 1997 Nov; 15(19):2267-75. PubMed ID: 9393872
[TBL] [Abstract][Full Text] [Related]
17. Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.
DeLuca C; Roulston A; Koromilas A; Wainberg MA; Hiscott J
J Virol; 1996 Aug; 70(8):5183-93. PubMed ID: 8764027
[TBL] [Abstract][Full Text] [Related]
18. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
19. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex.
Heilker R; Freuler F; Pulfer R; Di Padova F; Eder J
Eur J Biochem; 1999 Jan; 259(1-2):253-61. PubMed ID: 9914500
[TBL] [Abstract][Full Text] [Related]
20. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]